Skip to main content
Equibles
IKT logo

IKT · Inhibikase Therapeutics, Inc. · Investor Relations

Track IKT — free

Use IKT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IKT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.71 +0.07 (+3.95%)
Russell 2000 member Rebalance outlook locked
Market Cap
$229.54M
Shares
139.54M
Volume · Oct 20 352.25K Avg daily vol (3M) 604.94K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date Event Type
2026-06-26 2026 Annual Meeting of Stockholders Shareholder meeting

Source: https://www.inhibikase.com/investors

Key facts CIK 1750149 CUSIP 45719W205 13F (30d) 7 filings 7 filers Visit website Investor relations